Collaborations (Details Narrative) - USD ($) |
12 Months Ended | |||
|---|---|---|---|---|
Oct. 27, 2025 |
Dec. 31, 2025 |
Jun. 09, 2025 |
Aug. 03, 2022 |
|
| Phase 1b Clinical Trial [Member] | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Estimated agreement cost | $ 3,000,000 | |||
| Expense amount | $ 564,000 | |||
| Accrued expense | $ 521,000 | |||
| Phase 2a Clinical Trial [Member] | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Estimated agreement cost | $ 6,900,000 | |||
| Prepaid reservation fee | $ 1,700,000 | |||
| NIH/NIAID Award [Member] | ||||
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] | ||||
| Award amount received | $ 500,000 |
| X | ||||||||||
- Definition Estimated agreement cost. No definition available.
|
| X | ||||||||||
- Definition Prepaid resevation fee. No definition available.
|
| X | ||||||||||
- Definition Sum of the carrying values as of the balance sheet date of obligations incurred through that date, including liabilities incurred and payable to vendors for goods and services received, taxes, interest, rent and utilities, compensation costs, payroll taxes and fringe benefits (other than pension and postretirement obligations), contractual rights and obligations, and statutory obligations. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Excludes Selling, General and Administrative Expense. No definition available.
|
| X | ||||||||||
- Definition Cash received from grantors during the current period related to operating activities. This element represents receipts from a guarantor for the amount of guarantee provided. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|